Scientific Research Highlights St. Jude Medical's Comprehensive Chronic Pain Portfolio At The 12th INS World Congress

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announces that research investigators and scientists will present data from 32 accepted scientific abstracts or short articles at the International Neuromodulation Society (INS) 12th World Congress June 6-11 in Montreal, Canada. Throughout the congress, oral and poster presentations will highlight extensive research advancing St. Jude Medical’s product portfolio for the treatment of chronic pain, including presentations related to radiofrequency ablation (RFA), and spinal cord stimulation (SCS) including a focus on both Burst stimulation and stimulation of the dorsal root ganglion (DRG).

Help employers find you! Check out all the jobs and post your resume.